+91 22 67261000
info@guficbio.com
Toggle navigation
Home
About Us
Overview
GUFIC Group
Operations
R & D
Quality
Plants and Facilities
Contract Manufacturing
Bulk Drugs
Marketing and Sales
India
Spark
Criticare
Herbal
Ferticare
International
GUFIC STRIDDEN
Products
Pharmaceutical
Spark
Criti Care
Ferticare
Herbal
API / Bulk Drugs
Personal care
International
Investors
Disclosures under Regulation 46
of the SEBI (LODR) Regulations,
2015
Details of Business
MOA & AOA
Brief Profile of Board of Directors
Corporate Governance
Composition of board
Corporate Governance Reports
Secretarial Compliance Report
Shareholding pattern
Codes/Policies
Regulation 30
Credit Rating
Newspaper Advertisement
General Meeting
Notices
Annual Reports
Business Responsibility Report
Annual Return
E-voting Results
Intimation
Proceedings of Annual General Meeting
Postal Ballot
Quarterly results
Board Meeting
Intimation & Outcome
Notices
Financial Statement of Subsidiaries
Gufic UK Limited
Gufic Prime Private Limited
Veira Life FZE
Investors Services
Company Secretary & Compliance Officer
Investor communications
Investor Grievance Report
Investors Redressal
Event based Compliances
Scheme Of Amalgamation
Reclassification of Share
UPDATES
Investor/Analyst Meeting
Related Party Transaction
Gufic IEPF
Environmental Compliance
Updates
Trading Window Closure
Other Policies
EQUAL OPPOURTUNITY POLICY
HUMAN RIGHTS POLICY
CODE OF CONDUCT – STAKEHOLDERS
ANTI – CORRUPTION & ANTI-FRAUD POLICY
Media
Life @ Gufic
Events @ Gufic
Gufic in the News
Careers
Contact
Investor Services
LUPROCARE 3.75 mg 3D Details
[<< Back]
